Bain Capital Specialty Finance Stock Price, News & Analysis (NYSE:BCSF)

Bain Capital Specialty Finance trades on the New York Stock Exchange (NYSE) under the ticker symbol "BCSF."

Bain Capital Specialty Finance declared a quarterly dividend on Wednesday, August 7th. Shareholders of record on Monday, September 30th will be given a dividend of $0.41 per share on Wednesday, October 30th. This represents a $1.64 annualized dividend and a yield of 8.83%. The ex-dividend date of this dividend is Friday, September 27th. View Bain Capital Specialty Finance's Dividend History.

Bain Capital Specialty Finance Inc (NYSE:BCSF) issued its earnings results on Wednesday, August, 7th. The company reported $0.41 earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of $0.42 by $0.01. The firm earned $50.60 million during the quarter, compared to analysts' expectations of $44.28 million. Bain Capital Specialty Finance had a return on equity of 8.27% and a net margin of 44.83%. View Bain Capital Specialty Finance's Earnings History.

Bain Capital Specialty Finance is scheduled to release their next quarterly earnings announcement on Wednesday, November 6th 2019. View Earnings Estimates for Bain Capital Specialty Finance.

Bain Capital Specialty Finance will be holding an earnings conference call on Wednesday, November 6th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

5 brokers have issued 1-year target prices for Bain Capital Specialty Finance's shares. Their forecasts range from $20.00 to $20.50. On average, they expect Bain Capital Specialty Finance's share price to reach $20.25 in the next twelve months. This suggests a possible upside of 9.0% from the stock's current price. View Analyst Price Targets for Bain Capital Specialty Finance.

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Bain Capital Specialty Finance in the last year. There are currently 2 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Bain Capital Specialty Finance.

News articles about BCSF stock have trended negative recently, according to InfoTrie Sentiment Analysis. The research firm identifies negative and positive news coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Bain Capital Specialty Finance earned a daily sentiment score of -2.6 on InfoTrie's scale. They also gave headlines about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the stock's share price in the next several days. View News Stories for Bain Capital Specialty Finance.

Bain Capital Specialty Finance saw a increase in short interest during the month of September. As of September 30th, there was short interest totalling 396,300 shares, an increase of 33.8% from the August 30th total of 296,100 shares. Based on an average daily volume of 149,300 shares, the short-interest ratio is currently 2.7 days. Approximately 0.8% of the shares of the company are sold short. View Bain Capital Specialty Finance's Current Options Chain.

Some companies that are related to Bain Capital Specialty Finance include Verra Mobility (VRRM), GS ACQUISITION /SH CL A (GSAH), Global Cord Blood (CO), HAYMAKER ACQUIS/SH CL A (HYAC), Trinity Merger (TMCX), Repay (RPAY), THUNDER BRDG AC/SH SH (TBRG), Pivotal Acquisition (PVT), FORUM MERGER II/SH CL A (FMCI), Opes Acquisition (OPES), ANDINA ACQUISIT/SH SH (ANDA), AgroFresh Solutions (AGFS), Allied Esports Entertainment (AESE), KBL MERGER CORP/SH (KBLM) and Pensare Acquisition (WRLS).

Based on aggregate information from My MarketBeat watchlists, some companies that other Bain Capital Specialty Finance investors own include Verizon Communications (VZ), Home Depot (HD), Cisco Systems (CSCO), Honeywell International (HON), Johnson & Johnson (JNJ), Thermo Fisher Scientific (TMO), Amgen (AMGN), Alibaba Group (BABA), Procter & Gamble (PG) and CSX (CSX).

(BCSF) raised $156 million in an IPO on Thursday, November 15th 2018. The company issued 7,500,000 shares at a price of $20.25-$21.25 per share. BofA Merrill Lynch, Goldman Sachs, Morgan Stanley, Citigroup, Credit Suisse, Keefe, Bruyette & Woods (A Stifel Company) and Wells Fargo Securities served as the underwriters for the IPO and Janney Montgomery Scott, JMP Securities and Academy Securities were co-managers.

Bain Capital Specialty Finance's stock is owned by many different of institutional and retail investors. Top institutional investors include Starr International Co. Inc. (1.36%) and C.V. Starr & Co. Inc. Trust (0.68%). Company insiders that own Bain Capital Specialty Finance stock include Clare Stack Richer, Jeffrey B Hawkins, Michael A Ewald and Michael John Boyle. View Institutional Ownership Trends for Bain Capital Specialty Finance.

BCSF stock was acquired by a variety of institutional investors in the last quarter, including Starr International Co. Inc. and C.V. Starr & Co. Inc. Trust. Company insiders that have bought Bain Capital Specialty Finance stock in the last two years include Clare Stack Richer, Jeffrey B Hawkins, Michael A Ewald and Michael John Boyle. View Insider Buying and Selling for Bain Capital Specialty Finance.

Shares of BCSF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of BCSF stock can currently be purchased for approximately $18.58.

Bain Capital Specialty Finance has a market capitalization of $959.66 million and generates $99.29 million in revenue each year. The company earns $26.65 million in net income (profit) each year or $1.45 on an earnings per share basis. View Additional Information About Bain Capital Specialty Finance.

The official website for Bain Capital Specialty Finance is http://www.baincapitalbdc.com/.

Bain Capital Specialty Finance's mailing address is 200 CLARENDON STREET 37TH FLOOR, BOSTON MA, 02116. The company can be reached via phone at 617-516-2000 or via email at [email protected]